Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)?
Whitney Wooderchak‐Donahue(University of Utah), Gülsen Akay(Zeynep Kamil Hospital), Kevin J. Whitehead(University of Utah), Eric Briggs(ARUP Institute for Clinical and Experimental Pathology), David A. Stevenson(Stanford University), Brendan O’Fallon(ARUP Laboratories (United States)), Matthew Velinder(University of Utah), Andrew Farrell(University of Utah), Wei Shen(ARUP Institute for Clinical and Experimental Pathology), Emma Bedoukian(Children's Hospital of Philadelphia), Cara M. Skrabann(Children's Hospital of Philadelphia), Richard J. Antaya(Yale University), Kate Henderson(Yale University), Jeffrey Pollak(Yale University), James R. Treat(Children's Hospital of Philadelphia), Ronald W. Day(University of Utah), Joseph E. Jacher(University of Michigan), Mark Hannibal(University of Michigan), Kelly Bontempo(Advocate Children's Hospital), Gábor Marth(University of Utah), Pınar Bayrak‐Toydemir(University of Utah), Jamie McDonald(University of Utah)
Cited by 58Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis